Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... including its full prescribing information, visit www.ENTEREG.com. In collaboration with GlaxoSmithKline (GSK), the Company launched ENTEREG in mid-2008. The Company's research ...
2009 NOV 23 ... first commercialized product, Abreva® (docosanol), is marketed in North America by GlaxoSmithKline Consumer Healthcare and is the leading over-the-counter product for the treatment of ...
2009 NOV 23 ... receive a $12 million milestone payment under the company's strategic alliance with GlaxoSmithKline. The Phase 1b study will be used to assess the ability of CTP-518 to maintain acceptable ...
2009 NOV 28 ... to work, whether it's from home, on the road or from an office. Clients such as Google, GlaxoSmithKline, and Nokia join thousands of growing small and medium businesses that benefit from ...
2009 NOV 23 ... It services globally or regionally brands from Pfizer, Bristol-Myers Squibb, Roche, GlaxoSmithKline, Johnson & Johnson, and Schering-Plough, among others. "With the diversity ...
2009 NOV 23 ... by Novartis, and before that Mr. Pien held positions of increasing responsibility at GlaxoSmithKline and its predecessor, SmithKline Beecham, at Abbott Laboratories and at Merck & Co. He is ...
2009 NOV 23 ... a potent CB2 agonist with high CNS penetration," wrote G.M.P. Giblin and colleagues, GlaxoSmithKline. The researchers concluded: "This compound was efficacious in the acute ...
2009 NOV 23 ... "Albiglutide, under development by GlaxoSmithKline plc for the treatment of type 2 diabetes mellitus (T2DM), is an albumin-fusion peptide. ...
2009 NOV 23 ... Parker Waichman Alonso LLP announces that they have filed a lawsuit against GlaxoSmithKline and Procter & Gamble on behalf of an Nebraska woman who was diagnosed with neuropathy ...
2009 NOV 23 ... receptor 2 (HER2) targeting therapies -- which include Roche/Chugai's Herceptin and GlaxoSmithKline/Nippon Kayaku's Tykerb/Tyverb -- were the highest-selling drug class in breast cancer ...
2009 NOV 16 ... called ImmunoCAP. Prior to joining Phadia, John worked with industry leaders such as GlaxoSmithKline, Orthobiotech and Novartis Pharmaceuticals. Rubin brings more than 10 years of ...
2009 NOV 16 ... and biotechnology companies, including Bristol-Myers Squibb, sanofi-aventis, GlaxoSmithKline, Genentech, Boehringer Ingelheim, Wyeth Pharmaceuticals, and Daiichi-Sankyo. For more ...
2009 NOV 16 ... Nanobac Pharmaceuticals to Take Over DNAPrint Genomics GlaxoSmithKline to Take Over Genelabs Technologies Invitrogen Merges with Applied ...
2009 NOV 16 ... would complement existing interventions, such as bed nets and effective drug therapies. GlaxoSmithKline Biologicals' (GSK Bio) RTS,S is the first malaria vaccine candidate to demonstrate ...
